Zhao C - Search Results

1

Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.

Fu Y, Su L, Cai M, Yao B, Xiao S, He Q, Xu L, Yang L, Zhao C, Wan T, Shao L, Wang L, Huang X. Fu Y, et al. Among authors: zhao c. Mol Carcinog. 2019 Nov;58(11):2026-2039. doi: 10.1002/mc.23095. Epub 2019 Aug 9. Mol Carcinog. 2019. PMID: 31397502 Free PMC article.

2

Discovery and identification of new non-ATP competitive FGFR1 inhibitors with therapeutic potential on non-small-cell lung cancer.

Wang Y, Cai Y, Ji J, Liu Z, Zhao C, Zhao Y, Wei T, Shen X, Zhang X, Li X, Liang G. Wang Y, et al. Among authors: zhao y, zhao c. Cancer Lett. 2014 Mar 1;344(1):82-89. doi: 10.1016/j.canlet.2013.10.016. Cancer Lett. 2014. PMID: 24513267

3

L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway.

Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R, Zhao C. Bai E, et al. Among authors: zhao c. Cancer Manag Res. 2018 Mar 23;10:565-581. doi: 10.2147/CMAR.S159090. eCollection 2018. Cancer Manag Res. 2018. PMID: 29606890 Free PMC article.

4

Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.

Zheng H, Yang L, Kang Y, Chen M, Lin S, Xiang Y, Li C, Dai X, Huang X, Liang G, Zhao C. Zheng H, et al. Among authors: zhao c. Mol Carcinog. 2019 Apr;58(4):565-576. doi: 10.1002/mc.22951. Epub 2019 Jan 4. Mol Carcinog. 2019. PMID: 30520143

5

Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.

Yin C, Dai X, Huang X, Zhu W, Chen X, Zhou Q, Wang C, Zhao C, Zou P, Liang G, Rajamanickam V, Wang O, Zhang X, Cui R. Yin C, et al. Among authors: zhao c. J Cell Mol Med. 2019 Mar;23(3):2194-2206. doi: 10.1111/jcmm.14139. Epub 2019 Jan 4. J Cell Mol Med. 2019. PMID: 30609207 Free PMC article.

6

Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway.

Yang L, Lin S, Kang Y, Xiang Y, Xu L, Li J, Dai X, Liang G, Huang X, Zhao C. Yang L, et al. Among authors: zhao c. J Exp Clin Cancer Res. 2019 Jan 23;38(1):31. doi: 10.1186/s13046-018-1015-9. J Exp Clin Cancer Res. 2019. PMID: 30674340 Free PMC article.

7

Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway.

Yang L, Li J, Xu L, Lin S, Xiang Y, Dai X, Liang G, Huang X, Zhu J, Zhao C. Yang L, et al. Among authors: zhao c. Cancer Manag Res. 2019 Feb 1;11:1167-1176. doi: 10.2147/CMAR.S171517. eCollection 2019. Cancer Manag Res. 2019. PMID: 30774444 Free PMC article.

8

Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer.

Zhao C, Cao W, Zheng H, Xiao Z, Hu J, Yang L, Chen M, Liang G, Zheng S, Zhao C. Zhao C, et al. Int J Nanomedicine. 2019 Feb 28;14:1597-1618. doi: 10.2147/IJN.S189923. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30880968 Free PMC article.

9

Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway.

Xu L, Qiu S, Yang L, Xu H, Liu X, Fan S, Cui R, Fu W, Zhao C, Shen L, Wang L, Huang X. Xu L, et al. Among authors: zhao c. Mol Carcinog. 2019 Aug;58(8):1512-1525. doi: 10.1002/mc.23038. Epub 2019 May 8. Mol Carcinog. 2019. PMID: 31069881

10

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy.

Lin S, Yang L, Yao Y, Xu L, Xiang Y, Zhao H, Wang L, Zuo Z, Huang X, Zhao C. Lin S, et al. Among authors: zhao h, zhao c. J Exp Clin Cancer Res. 2019 Jul 8;38(1):293. doi: 10.1186/s13046-019-1303-z. J Exp Clin Cancer Res. 2019. PMID: 31287013 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,355 results

Search Page

Filters